Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05076110 · ClinicalTrials.gov registry record · Phase 4
Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures
A Phase 4 study of Hip Arthroscopy, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 188
- Enrollment target
- 1
- Study location
NCT05076110: Recruiting Phase 4 study of Hip Arthroscopy, sponsored by Mayo Clinic.
NCT05076110 is a Phase 4 study of Hip Arthroscopy that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 188 participants, below the 1,108-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05076110, a Phase 4 study of Hip Arthroscopy, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 188 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.
Primary Outcome
The change in pain score measured using a visual analog scale (VAS) to rate pain on a scale 0-10; 0=no pain to 10=worst possible pain with higher scores indicating worsening pain.
Conditions Studied
Interventions
- DRUG Acetaminophen
- DRUG Ibuprofen
- DRUG Oxycodone
- DRUG Gabapentin
- DRUG Methocarbamol
Study Locations (1)
Minnesota
- Mayo clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2022-04-07 |
| Est. Completion | 2026-04 |
| Phase | Phase 4 |
What NCT05076110 shows while recruiting
NCT05076110 is an interventional study that assigns participants to a tested intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap, below the 1,108-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Hip Arthroscopy appearing as the primary indexed condition, and to 5 interventions - of which Acetaminophen is the first listed.
NCT05076110 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05076110 about?
NCT05076110 is a clinical study titled "Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures". This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.
What is the current status of trial NCT05076110?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 188 participants. The study started on 2022-04-07. Estimated completion is 2026-04.
What conditions does trial NCT05076110 study?
This clinical trial studies the following conditions: Hip Arthroscopy.
What interventions are being tested in trial NCT05076110?
The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), Oxycodone (DRUG), Gabapentin (DRUG), Methocarbamol (DRUG).
Who is sponsoring clinical trial NCT05076110?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05076110 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Arthroscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05076110's enrollment target sits among peer trials
188 4th of 10 higher than 7 of 10 other Hip Arthroscopy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hip Arthroscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial
RECRUITING · Phase 4
-
Absorbable vs Non-Absorbable Sutures for Hip Capsular Closure
RECRUITING · NA
-
Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery
RECRUITING · Phase 2
-
An Evaluation of Hip Preservation Outcomes
RECRUITING
-
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
ACTIVE NOT RECRUITING · NA
-
Effect of Post-operative Brace on Pain and Patient Outcomes Following Hip Arthroscopy for FAIS
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI